Biopharma Business

Tag "option agreement"

Agreement formed to develop and commercialise infectious diseases programme

    Agreement formed to develop and commercialise infectious diseases programme

Visterra and Vir Biotechnology have entered into a research collaboration, exclusive licence and option agreement for the development and commercialisation of select programmes for infectious diseases. The programmes will be

Read Full Article

Upcoming Events

[eventlist]

The Magazine

New Subscriber

Subscribe Here



Advertisements